Analyst Ratings for ShockWave Medical

ShockWave Medical SWAV has observed the following analyst ratings within the last quarter:

Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago
Bullish 0 2 0 1
Somewhat Bullish 1 1 0 0
Indifferent 0 1 1 0
Somewhat Bearish 0 0 0 0
Bearish 0 0 0 0

In the last 3 months, 10 analysts have offered 12-month price targets for ShockWave Medical. The company has an average price target of $157.2 with a high of $202.00 and a low of $130.00.

price target chart

This current average has increased by 15.87% from the previous average price target of $135.67.

What Are Analyst Ratings?

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Analysts may suggest actions like "buy", "sell", "hold", or similar verbage for each stock based on research compiled from the corresponding company. Analysts who suggest "buy" are telling traders to purchase the stock based on forecasted growth. On the flip side, analysts who suggest "sell" are telling traders to dump the stock because of a similarly forecasted decline. Analysts who suggest "hold" are telling investors that they see short-term or mid-term stagnation and to maintain their positions on the stock.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!